Medscape is the leading online global destination for physicians and healthcare professionals worldwide, offering the latest medical news and expert perspectives; essential point-of-care drug and disease information; and relevant professional education and CME.

Medscape

Medscape Education

Medscape Professional Network

Medscape Medical Affairs

MedscapeLIVE

Medscape édition française

Medscape Português

Medscape UK

Medscape Español

Our Mission:
To improve patient care with comprehensive clinical information and resources essential to physicians and healthcare professionals.

Our Company:
Medscape is the leading online global destination for physicians and healthcare professionals worldwide, offering the latest medical news and expert perspectives; essential point-of-care drug and disease information; and relevant professional education and CME.

Medscape has over 30 distinct specialty sites for physicians, plus sites for nurses, pharmacists, dentists, and medical students.

All content on Medscape.com and Medscape.org is available for free.

Highland Capital Partners

Researchers reporting in Vancouver at the annual meeting of the American College of Gastroenterology have identified a higher risk of inflammatory bowel disease (IBD) among adults who consumed a diet rich in ultra-processed foods, suggesting another field for inquiry about the potential role of industrial-produced edible food products in IBD.

The study, which was a meta-analysis of four studies, found a 47% greater risk of IBD in adults who consumed high levels of ultra-processed foods, compared with adults in reference groups.

“Our data are also consistent with other observational studies that found increased consumption of junk food, along with reduced intakes of fresh fruit and vegetables, are associated with the development of IBD. Because Americans consume over 60% of their calories in the form of ultra-processed foods, reductions in this level of consumption could meaningfully decrease the incidence of IBD,” wrote authors who were led by Eric Hecht, MD, PhD, MPH, president and executive director of the nonprofit Institute of Etiological Research, Boca Raton, Fla.

With nutrient-stimulated hormone therapies for obesity in phase 3 trials, and activin-receptor inhibitors the next upcoming drug class, highly effective treatments for obesity are on the horizon.

"We are at a watershed [moment] brought on by the recent introduction of highly effective antiobesity medications," said Ania M. Jastreboff, MD, PhD, in a lecture at #ObesityWeek.

Join us for a live discussion that could transform the way you approach metastatic colorectal cancer treatment! Hear from an expert panel on advances in clinical trial data and real-world evidence to gain the knowledge you need to make informed treatment decisions for patients with mCRC.

This livestream is supported by an educational grant from Bayer.

More and more people are using companion robots to boost social connection, mental support, and overall health. The science suggests it’s more than a gimmick.

⏰ Happening today! Set your alarms to join us to hear experts talk about the latest in #mCRC.
#MedEd #ESMO23

➡️ Register to be notified of when we go live: http://ms.spr.ly/60489NYQ4

A recent editorial blamed ultraprocessed foods for the obesity epidemic, but Caroline Apovian, MD, explains why that's not necessarily true.

'On the other hand, we're treating marijuana as if it has no dangers, risks, or problems associated with it. It's a wonder substance that makes you feel better. Well, I don't think that's the right attitude to take toward marijuana either.'

Dr David Fajgenbaum, MD, MBA, MSc is alive thanks to a repurposed drug. Now his dream is to find cures for millions of people from among drugs we already have. #ChasingMyCure Every Cure 📽️ Catch the full interview here: http://ms.spr.ly/60489NJjC

Oncologists who receive money from the pharmaceutical industry appear more likely to prescribe nonrecommended and low-value drugs in some clinical scenarios, according to a recent analysis of fee-for-service Medicare claims.

New research is testing the theory that indulging in morbid curiosity and scary play can help us build psychological resilience, overcome phobias, and deal with genuine scares. 👻

COM:MEDSCAPE

Medscape

locale

market

industry

website

crunchbase

linkedin

peer of

competitor of

Metrics